Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Sugarbud Craft Growers (SUGR) has announced key financial and operating results for the three months ended March 31, 2022
  • The company anticipates announcing its first quarter 2022 financial statements after-market on Monday, May 30, 2022
  • Sugarbud expects to record gross revenue of between $925,000-$950,000 in Q1 2022, representing a 25 per cent increase over Q4, 2021
  • The company expects to record shipments of between 150,000 – 160,000 grams of dried cannabis in Q1 2022, a year over year increase of over 90 per cent vs Q1 2021
  • Sugarbud is a leading craft cannabis company focused on the cultivation and production of cannabis products
  • Sugarbud Craft Growers Corp. (SUGR) opened trading at C$0.55 per share

Sugarbud Craft Growers (SUGR) has announced key financial and operating results for the three months ended March 31, 2022.

The company anticipates announcing its first quarter 2022 financial statements and management’s discussion and analysis after-market on Monday, May 30, 2022.

Q1 2022 highlights

  • Revenue growth
    Sugarbud expects to record gross revenue of between $925,000-$950,000 in Q1 2022, representing a 25 per cent increase over Q4, 2021 and a 37 per cent year over year increase vs Q1 2021.
  • Record grams sold
    The company expects to record shipments of between 150,000 – 160,000 grams of dried cannabis in Q1 2022, representing a sequential increase of over 10 per cent vs. Q4 2021 and a year over year increase of over 90 per cent vs Q1 2021.

Sugarbud is a leading craft cannabis company focused on the cultivation and production of cannabis products.

Sugarbud Craft Growers Corp. (SUGR) opened trading at C$0.55 per share.

More From The Market Herald

" Avicanna (TSX:AVCN) partners with Shoppers Drug Mart for cannabis transition

Avicanna (AVCN) has been chosen by Shoppers Drug Mart as its partner to transition its Medical Cannabis by Shoppers business.
1CM Inc.

" 1CM (CSE:EPIC) collaborates with Herbidus Formulation to enter India cannabis industry

1CM (EPIC) announced that it has signed a Business Collaboration Agreement with Herbidus Formulations Pvt Ltd. (the Trost).

" Entourage’s (TSXV:ENTG) CBD-infused ‘functional gum’ joins emerging market

Entourage Health (ENTG) has expanded its medical portfolio with the launch of its new CBD chewing gum.

" Innocan Pharma (CSE:INNO) reports successful efficacy test for vaginal derma product

Innocan Pharma (INNO) has announced successful results from a controlled efficacy test of its vaginal derma product.